NEWS NEWS
Tuesday June 6, 8:11 am Eastern Time
Company Press Release
SOURCE: ConSyGen, Inc.
ConSyGen Board Approves Stock Repurchase Program
TEMPE, Ariz., June 6 /PRNewswire/ -- ConSyGen, Inc. (OTC Bulletin Board: CSGI -
news) announced today that its Board of Directors has approved a stock repurchase
program under which the Company is authorized to purchase up to 4.0 million shares or
approximately 20% of its common stock outstanding.
The stock, when purchased, will be used for corporate purposes. These purchases can
be made in the open market or in negotiated transactions from time to time, depending
upon market conditions.
The Board believes that the recent market price of the stock does not reflect the true value
of the Company. Accordingly, the repurchase program represents an attractive
investment opportunity for the Company. The Company wants to assure the investment
public that its Fiscal 2001 Projections are still intact.
A. Lewis Burridge, ConSyGen's Chief Executive and Chairman stated, ``We are pleased
that the Board has taken this action, providing another opportunity to strengthen the
company and our global position in the marketplace.''
Jason Genet, ConSyGen's Chief Operating Officer said, ``With our Business Plan firmly in
place, we are confident that our revenue projections will hit their mark and lead us into a
profitable future.''
About ConSyGen, Inc.
ConSyGen's business is customer-driven, technology-influenced and service-oriented,
coupled with world-class software development. In order to achieve the core company
goals, various business units have the responsibility for developing cohesive missions,
quantifiable objectives and comprehensive strategies. These business units include
E-Commerce, Internet Services, and Business Products.
Forward-looking statements involve risks and uncertainties that may cause actual results
to differ materially from those projected in such forward-looking statements. Factors which
could affect results include the development of competing or superior technologies,
market awareness, acceptance of ConSyGen's technology or products, overall market
demand for conversion services, the company's ability to attract and retain qualified
personnel, the companies ability to protect its propriety information and other risk factors
set forth in the company's SEC filings.
Contact: Jason Genet of ConSyGen, Inc., 480-394-9100, www.consygen.com.
SOURCE: ConSyGen, Inc. |
